The Zika Virus: A Global Issue in a Canadian Context

Last modified by Ann Watkins on 2016/02/25 15:13


Join us for this discussion on the Zika Virus outbreak that the World Health Organization (WHO) has deemed an international public health emergency.

The goal of this webinar is to highlight what is known of the disease, provide an overview from the global perspective and impact of the virus and to put this information into the context of what is relevant for Canadian paediatric health centres.  Experts in the epidemiology of the virus will  discuss the origin of the virus, its transmission, the demographic implications, and the global impact.

We will then hear from Canadian health services and policy experts who will put that information into the 'Canadian context'; What do we need to prepare for, what are the real concerns, what precautions when repatriating/transporting patients need to be taken, how do we pro actively inform healthcare policy or inform the stakeholders of what policies may be in place from a public health perspective that the community should be aware of.  

We hope you will us in this conversation and take this opportunity to add your thoughts, ask your questions and find out what your colleagues are doing across the country.


Presentation Slides


JonathanGubbay2012webphoto.jpgDr. Jonathan Gubbay MBBS, FRCPC

Jonathan Gubbay is the medical microbiologist for the virus detection, arboviruses and respiratory bacteriology laboratories at Public Health Ontario, and is the laboratory lead for emerging viral pathogens at PHO laboratories. He is an assistant professor in the Departments of Laboratory Medicine and Pathobiology and Pediatrics at the University of Toronto and part time staff physician in the Division of Infectious Diseases, The Hospital for Sick Children. He has a research interest in the molecular epidemiology and diagnosis of respiratory viral infections and emergence of antiviral resistance. His research involves application of molecular methods to help understand the epidemiology and genetic heterogeneity of viruses, with a focus on respiratory viruses.

KMurphy.jpgKellie E. Murphy MD MSc FRCSC FACOG   

Dr. Kellie Murphy completed her obstetrical residency program at Albert Einstein College of Medicine in New York City in 1995.  She then completed a Maternal-Fetal Medicine fellowship program and a Master of Epidemiology at Columbia Presbyterian Medical Center and School of Public Health in New York.  In July of 1998, she joined the department of Obstetrics and Gynecology at the University of Toronto where she is currently an Associate Professor, based out of Mount Sinai Hospital.  In addition, she holds a joint appointment with the Clinical Epidemiology and the Department of Health Policy Management and Evaluation at the University of Toronto.  She was the Principle Investigator of the international multicenter randomized controlled trial, Multiple courses of Antenatal Corticosteroids for preterm birth Study (MACS).  Her primary research interests include prematurity, infectious disease, clinical trials and perinatal epidemiology.

Created by Ann Watkins on 2016/02/02 19:44